Breast imaging illustration
High-Risk Lesions

Atypical Lobular Hyperplasia

ALH is not cancer - but it is a high-risk lesion that elevates future breast cancer risk equally in both breasts.

Upload Report
Quick Take: Atypical lobular hyperplasia (ALH) is a non-cancerous overgrowth of abnormal cells in the breast lobules. It is not cancer. It is a high-risk lesion indicating elevated future breast cancer risk. Found in approximately 1–4% of breast biopsies.
High-risk lesion: High-risk lesions are not cancer, but they can be associated with a higher risk of developing cancer or may require surgical removal in some cases.

Where ALH Fits - The Lobular Neoplasia Spectrum

Lobular Neoplasia Spectrum

Normal Lobule
ALH ← You Are Here
LCIS

ALH and LCIS are the same type of abnormal cell - the difference is quantity. ALH fills less than 50% of the lobular units involved. LCIS fills more than 50%. Both are risk markers, not cancer.

What Exactly Is ALH?

ALH is a hyperplasia - an overgrowth of cells - located in the lobules (the small milk-producing glands at the end of each duct). The cells in ALH are abnormal: small, round, uniform, and non-cohesive. ALH is almost always found incidentally - discovered when a biopsy was performed for a different imaging finding.

ALH is a pathology finding - the radiologist's role after an ALH diagnosis is radiologic-pathologic correlation: does the ALH finding explain the imaging target that prompted the biopsy?

Concordance - Why It Matters

Concordant

The ALH finding adequately explains the imaging target. Close imaging surveillance may be acceptable - discuss with your breast surgeon. Some institutions still favor excision.

Discordant

The ALH finding does not explain the imaging finding that triggered the biopsy - meaning something else may have been missed. Surgical excision is recommended.

Key Numbers

5–10%

Upgrade rate to DCIS or invasive cancer at surgical excision

4–5×

Elevated lifetime breast cancer risk - in both breasts equally

Important distinction: The elevated cancer risk from ALH affects both breasts equally - not just the breast where ALH was found. This bilateral risk is a key reason why enhanced surveillance and risk-reduction strategies are discussed regardless of which breast was biopsied.

What Happens Next

Concordant, no other atypia
Close imaging surveillance may be acceptable

Discuss with your breast surgeon whether surveillance or surgical excision is right for your specific situation.

Discordant, or with other atypia (ADH)
Surgical excision recommended

Excision ensures no adjacent cancer was missed by the biopsy needle.

Excision returns benign (no upgrade)
Risk remains elevated - long-term surveillance continues

Risk reduction discussion (chemoprevention) should occur regardless of excision result.

Excision upgrades to DCIS or cancer
Treatment planning begins

Occurs in approximately 5–10% of cases.

Risk management
Chemoprevention and enhanced screening

MRI screening considered if overall lifetime risk reaches 20% or above.

When Should I Be Concerned?

Act promptly if:

Related Topics

Does your biopsy report mention ALH? The key question is whether it was concordant with your imaging finding and what the recommended next step is. A board-certified radiologist with subspecialty breast imaging experience can walk you through it step by step.

Get My Report Explained
This content is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider with any concerns about your breast health.